Epigral Ltd vs Kkalpana Industries India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Epigral Ltd is ₹ 852.25 as of 20 Mar 15:30 . The P/E Ratio of Epigral Ltd changed from 16 on March 2022 to 22.9 on March 2025 . This represents a CAGR of 9.38% over 4 yearsThe P/E Ratio of KKalpana Industries (India) Ltd changed from 8.6 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Epigral Ltd changed from ₹ 4045 crore on March 2022 to ₹ 8191 crore on March 2025 . This represents a CAGR of 19.29% over 4 yearsThe Market Cap of KKalpana Industries (India) Ltd changed from ₹ 205.55 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 years The revenue of Epigral Ltd for the Dec '25 is ₹ 602.68 crore as compare to the Sep '25 revenue of ₹ 589.1 crore. This represent the growth of 2.31% The revenue of KKalpana Industries (India) Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Epigral Ltd for the Dec '25 is ₹ 108.26 crore as compare to the Sep '25 ebitda of ₹ 133.8 crore. This represent the decline of -19.09% The ebitda of KKalpana Industries (India) Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Epigral Ltd changed from ₹ 85.87 crore to ₹ 39.11 crore over 7 quarters. This represents a CAGR of -36.20% The net profit of KKalpana Industries (India) Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Epigral Ltd changed from 5.88 % on March 2023 to 7.26 % on March 2025 . This represents a CAGR of 7.28% over 3 yearsThe Dividend Payout of KKalpana Industries (India) Ltd changed from 8.39 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Epigral Ltd

Epigral Limited was erstwhile incorporated as 'Meghmani Finechem Limited' in 2007, which is engaged in manufacturing and selling of Chlor Alkali & its Derivatives and also in Trading of Agrochemical products.
The Company was incorporated as a subsidiary of Meghmani Organics Limited. Meghmani Finechem Limited (MFL) was demerged from Meghmani Organics Limited (MOL) as a going concern, through the Scheme of Arrangement for Demerger and the said Scheme became effective from May 10, 2021.
The Chlor-Alkali business commissioned in 2009, growing from an installed capacity of 1,88,000 TPA in 2015 to 3,15,000 TPA at the close of FY 2020-21.
The Company is now among the leading players in India's chlor alkali industry.
In terms of the said Scheme, the Company allotted 2,39,03,029 Equity Shares of Rs 10/- each on 20th May, 2021 to the shareholders of Meghmani Organics Limited.

About KKalpana Industries (India) Ltd

Kalapana industries (India) Ltd was incorporated in September, 1985.
In priority, the Company was engaged in the business of manufacturing of PVC & XLPE Compounds and Embroidery of Fabrics.
Post Amalgamation, the Company recycles plastic and manufactures plastic granules.
It has 2 manufacturing units with state-of-the-art machinery, infrastructure, equipment, and R&D facilities.
With plants located at East Coast of India, the Company gains advantage of low freight costs. The company chalked out an expansion project at a cost of Rs.5 crores to increase the production capacities of XLPE. The commercial production is expected during the financial year of 2003-04. The Scheme of Amalgamation of KaIpana Plastics Pvt Ltd (KPPL) with the Company was made effective on 14 November, 2005.

FAQs for the comparison of Epigral Ltd and KKalpana Industries (India) Ltd

Which company has a larger market capitalization, Epigral Ltd or KKalpana Industries (India) Ltd?

Market cap of Epigral Ltd is 3,676 Cr while Market cap of KKalpana Industries (India) Ltd is 209 Cr

What are the key factors driving the stock performance of Epigral Ltd and KKalpana Industries (India) Ltd?

The stock performance of Epigral Ltd and KKalpana Industries (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Epigral Ltd and KKalpana Industries (India) Ltd?

As of March 23, 2026, the Epigral Ltd stock price is INR ₹852.25. On the other hand, KKalpana Industries (India) Ltd stock price is INR ₹22.25.

How do dividend payouts of Epigral Ltd and KKalpana Industries (India) Ltd compare?

To compare the dividend payouts of Epigral Ltd and KKalpana Industries (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.